Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
Not recruiting
Investigated diseases:Investigated drugs:
Study on Abemaciclib and Endocrine Therapy for Patients with Advanced Hormone Receptor Positive HER2 Negative Breast Cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer
Not recruiting
Investigated diseases:Investigated drugs:
powered by
